Sartorius 

€200
185
+€0.4+0.2% Wednesday 14:59

统计数据

当日最高
201
当日最低
197.8
52周最高
-
52周最低
-
成交量
432.15
平均成交量
-
市值
207.66M
市盈率
0.46
股息收益率
0.37%
股息
0.73

即将到来

股息

0.37%股息收益率
10年增长
11.31%
5年增长
3.66%
3年增长
1.41%
1年增长
-48.95%

收益

17Oct预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
0.14
0.95
1.76
2.58
预期每股收益
1.12081932688
实际每股收益
N/A

人们还关注

此列表基于关注0NIQ.LSE的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。
Thermo Fisher Scientific
TMO
市值234.95B
Thermo Fisher Scientific在生命科学领域提供广泛的产品和服务,直接与Sartorius在实验室设备和生物加工技术等领域竞争。
Danaher
DHR
市值194.5B
Danaher Corporation在生命科学、诊断和环境行业中运营,在生物加工和实验室设备领域与Sartorius竞争。
Bio-Rad Laboratories
BIO
市值9.35B
Bio-Rad Laboratories在生命科学研究和临床诊断市场提供产品和服务,与Sartorius竞争实验室仪器和耗材。
Agilent Technologies
A
市值41.06B
Agilent Technologies是生命科学、诊断和应用化学市场的领导者,提供与Sartorius实验室产品竞争的分析仪器。
Waters
WAT
市值20.56B
Waters Corporation专注于生命科学领域的分析仪器,与Sartorius竞争提供实验室设备和耗材。
PERKINELMER INC
PKI
市值16.9B
PerkinElmer为诊断、生命科学和应用市场提供仪器、耗材和服务,在几个实验室和研究领域与Sartorius竞争。
Bruker
BRKR
市值10.17B
Bruker Corporation提供科学仪器和分析和诊断解决方案,在生命科学研究和诊断领域与Sartorius竞争。
Mettler-Toledo International
MTD
市值30.54B
Mettler-Toledo International是一家精密仪器和服务提供商,在实验室设备和分析仪器领域与Sartorius竞争。
Repligen
RGEN
市值8.45B
Repligen Corporation提供生物加工技术和解决方案,直接与Sartorius在生物技术和制药制造领域竞争。
Illumina
ILMN
市值20.93B
Illumina, Inc. 专注于基因分析的测序和基于阵列的解决方案,在更广泛的生命科学市场上通过提供研究的补充技术间接与Sartorius 竞争。

关于

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Show more...
首席执行官
Dr. Joachim Kreuzburg
员工
13832
国家
DE
ISIN
DE0007165607

上市公司